speb/financial-data huggingface dataset:
AGN.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 13950835.00
AGN.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 13949835.00
AGN.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
AGN.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
AGN.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Assets: 16377555.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 13950835.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 13950835.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 2426720.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 1000.00
AGN.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGN.AX balance_sheet (annual, 2024-06-30) — Working Capital: 13949835.00
AGN.AX income_statement (annual, 2025-06-30) — +Operating Expense: 10896343.00
AGN.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 2884042.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2884042.00
AGN.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 127526030.00
AGN.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.06
AGN.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 15912660.00
AGN.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 29629950.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 29629950.00
AGN.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 10555160.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 10555160.00
AGN.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10555160.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10555160.00
AGN.AX balance_sheet (annual, 2025-06-30) — Cash Equivalents: 8050000.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 8050000.00
AGN.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 2505160.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 2505160.00
AGN.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: 346897.00
AGN.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
AGN.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: -5704397.00
AGN.AX cash_flow (annual, 2025-06-30) — Changes In Cash: -5357500.00
AGN.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -9416277.00
AGN.AX cash_flow (annual, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 3161552.00
AGN.AX balance_sheet (annual, 2025-06-30) — Common Stock: 29629950.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 29629950.00
AGN.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 7237271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 7237271.00
AGN.AX cash_flow (annual, 2025-06-30) — Common Stock Issuance: 346897.00
AGN.AX balance_sheet (annual, 2025-06-30) — Current Assets: 11038044.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 11038044.00
AGN.AX balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 615915.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 615915.00
AGN.AX balance_sheet (annual, 2025-06-30) — Current Deferred Revenue: 615915.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 615915.00
AGN.AX balance_sheet (annual, 2025-06-30) — Current Liabilities: 3801773.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3801773.00
AGN.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 127526030.00
AGN.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.06
AGN.AX income_statement (annual, 2025-06-30) — EBIT: -7169844.00
AGN.AX income_statement (annual, 2025-06-30) — EBITDA: -7169844.00
AGN.AX cash_flow (annual, 2025-06-30) — End Cash Position: 10555160.00
AGN.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: 346897.00
AGN.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: -5704397.00
AGN.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 340521.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 340521.00
AGN.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 2233326.00
AGN.AX balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 1000.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2025-06-30) — Interest Expense: 503.00
AGN.AX income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 503.00
AGN.AX income_statement (annual, 2025-06-30) — Interest Income: 512751.00
AGN.AX income_statement (annual, 2025-06-30) — Interest Income Non Operating: 512751.00
AGN.AX cash_flow (annual, 2025-06-30) — Interest Paid Direct: -503.00
AGN.AX cash_flow (annual, 2025-06-30) — Interest Paid Supplemental Data: 503.00
AGN.AX cash_flow (annual, 2025-06-30) — Interest Received Direct: 550831.00
AGN.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 7237271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7237271.00
AGN.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: 0.00
AGN.AX cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 346897.00
AGN.AX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: 346897.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Net Interest Income: 512248.00
AGN.AX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 512248.00
AGN.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 7236271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 7236271.00
AGN.AX income_statement (annual, 2025-06-30) — Normalized EBITDA: -7169844.00
AGN.AX income_statement (annual, 2025-06-30) — Normalized Income: -7170347.00
AGN.AX income_statement (annual, 2025-06-30) — Operating Income: -10896343.00
AGN.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 128445190.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 128445190.00
AGN.AX cash_flow (annual, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 2757459.00
AGN.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 340521.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 340521.00
AGN.AX income_statement (annual, 2025-06-30) — Other Gand A: 444891.00
AGN.AX income_statement (annual, 2025-06-30) — Other Income Expense: 3213748.00
AGN.AX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 1000.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: 3213748.00
AGN.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 354739.00
AGN.AX balance_sheet (annual, 2025-06-30) — Other Payable: 243558.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 243558.00
AGN.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 421451.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 421451.00
AGN.AX balance_sheet (annual, 2025-06-30) — Payables: 3127600.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Payables: 3127600.00
AGN.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 3127600.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3127600.00
AGN.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -9416277.00
AGN.AX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 58258.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 58258.00
AGN.AX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 61433.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 61433.00
AGN.AX income_statement (annual, 2025-06-30) — Pretax Income: -7170347.00
AGN.AX cash_flow (annual, 2025-06-30) — Receiptsfrom Government Grants: 404093.00
AGN.AX balance_sheet (annual, 2025-06-30) — Receivables: 421451.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 421451.00
AGN.AX income_statement (annual, 2025-06-30) — Research And Development: 8132295.00
AGN.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: -22733200.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -22733200.00
AGN.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 1788435.00
AGN.AX income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 175983.00
AGN.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 2409309.00
AGN.AX balance_sheet (annual, 2025-06-30) — Share Issued: 128445190.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 128445190.00
AGN.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 7237271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 7237271.00
AGN.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 7236271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7236271.00
AGN.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AGN.AX income_statement (annual, 2025-06-30) — Tax Provision: 0.00
AGN.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Assets: 11039044.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 11039044.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 7237271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7237271.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 7237271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 7237271.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 3801773.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3801773.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 1000.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1000.00
AGN.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGN.AX balance_sheet (annual, 2025-06-30) — Working Capital: 7236271.00
AGN.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 7236271.00
AGNC balance_sheet (annual, 2021-12-31) — Accounts Payable: 400000000.00
AGNC cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -17000000.00
AGNC cash_flow (annual, 2021-12-31) — Common Stock Payments: -281000000.00
AGNC cash_flow (annual, 2021-12-31) — Preferred Stock Payments: 0.00
AGNC cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -281000000.00
AGNC income_statement (annual, 2022-12-31) — +Total Revenue: -1116000000.00
AGNC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14186000000.00
AGNC balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 3677000000.00
AGNC income_statement (annual, 2022-12-31) — Basic Average Shares: 537000000.00
AGNC income_statement (annual, 2022-12-31) — Basic EPS: -2.41
AGNC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1525000000.00
AGNC balance_sheet (annual, 2022-12-31) — Capital Stock: 1640000000.00
AGNC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1018000000.00
AGNC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 8956000000.00
AGNC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -869000000.00
AGNC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -11392000000.00
AGNC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 11188000000.00
AGNC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1013000000.00
AGNC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 38000000.00
AGNC cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 69000000.00
AGNC cash_flow (annual, 2022-12-31) — Change In Working Capital: 107000000.00
AGNC cash_flow (annual, 2022-12-31) — Changes In Cash: 809000000.00
AGNC balance_sheet (annual, 2022-12-31) — Common Stock: 6000000.00
AGNC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6236000000.00
AGNC cash_flow (annual, 2022-12-31) — Common Stock Issuance: 526000000.00
AGNC cash_flow (annual, 2022-12-31) — Common Stock Payments: -51000000.00
AGNC balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 99000000.00
AGNC income_statement (annual, 2022-12-31) — Diluted Average Shares: 537000000.00
AGNC income_statement (annual, 2022-12-31) — Diluted EPS: -2.41
AGNC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1295000000.00
AGNC balance_sheet (annual, 2022-12-31) — Dividends Payable: 100000000.00
AGNC cash_flow (annual, 2022-12-31) — End Cash Position: 2334000000.00
AGNC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -11392000000.00
AGNC cash_flow (annual, 2022-12-31) — Free Cash Flow: 1013000000.00
AGNC cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 2916000000.00
AGNC income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2081000000.00
AGNC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -672000000.00
AGNC income_statement (annual, 2022-12-31) — General And Administrative Expense: 41000000.00
AGNC balance_sheet (annual, 2022-12-31) — Goodwill: 526000000.00
AGNC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNC income_statement (annual, 2022-12-31) — Interest Expense: 625000000.00
AGNC income_statement (annual, 2022-12-31) — Interest Income: 1590000000.00
AGNC cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 557000000.00
AGNC balance_sheet (annual, 2022-12-31) — Invested Capital: 6331000000.00
AGNC cash_flow (annual, 2022-12-31) — Investing Cash Flow: 11188000000.00
AGNC balance_sheet (annual, 2022-12-31) — Investments And Advances: 3677000000.00
AGNC cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 671000000.00
AGNC balance_sheet (annual, 2022-12-31) — Long Term Debt: 95000000.00
AGNC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 95000000.00
AGNC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -24000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 475000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income: -1190000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1295000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1190000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1190000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1190000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1190000000.00
AGNC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1190000000.00
AGNC income_statement (annual, 2022-12-31) — Net Interest Income: 965000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 7187000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -24000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -24000000.00
AGNC cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 145000000.00
AGNC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7344000000.00
AGNC income_statement (annual, 2022-12-31) — Normalized Income: -1190000000.00
AGNC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1013000000.00
AGNC cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1714000000.00
AGNC income_statement (annual, 2022-12-31) — Operating Revenue: -1116000000.00
AGNC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 574600000.00
AGNC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -672000000.00
AGNC income_statement (annual, 2022-12-31) — Other Non Interest Expense: 33000000.00
AGNC balance_sheet (annual, 2022-12-31) — Other Payable: 302000000.00
AGNC balance_sheet (annual, 2022-12-31) — Other Receivables: 120000000.00
AGNC balance_sheet (annual, 2022-12-31) — Payables: 402000000.00
AGNC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 402000000.00
AGNC balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 67500000.00
AGNC balance_sheet (annual, 2022-12-31) — Preferred Stock: 1634000000.00
AGNC income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 105000000.00
AGNC balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1634000000.00
AGNC cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 145000000.00
AGNC income_statement (annual, 2022-12-31) — Pretax Income: -1190000000.00
AGNC cash_flow (annual, 2022-12-31) — Purchase Of Investment: -55509000000.00
AGNC balance_sheet (annual, 2022-12-31) — Receivables: 120000000.00
AGNC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -24000000.00
AGNC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -51000000.00
AGNC balance_sheet (annual, 2022-12-31) — Retained Earnings: -7284000000.00
AGNC income_statement (annual, 2022-12-31) — Salaries And Wages: 41000000.00
AGNC cash_flow (annual, 2022-12-31) — Sale Of Investment: 62696000000.00
AGNC income_statement (annual, 2022-12-31) — Selling General And Administration: 41000000.00
AGNC balance_sheet (annual, 2022-12-31) — Share Issued: 574600000.00
AGNC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2000000.00
AGNC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7870000000.00
AGNC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5710000000.00
AGNC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AGNC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
AGNC balance_sheet (annual, 2022-12-31) — Total Assets: 51748000000.00
AGNC balance_sheet (annual, 2022-12-31) — Total Capitalization: 7965000000.00
AGNC balance_sheet (annual, 2022-12-31) — Total Debt: 95000000.00
AGNC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7870000000.00
AGNC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 43878000000.00
AGNC cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 3795000000.00
AGNC income_statement (annual, 2023-12-31) — +Total Revenue: 251000000.00
AGNC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15281000000.00
AGNC balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 4242000000.00
AGNC income_statement (annual, 2023-12-31) — Basic Average Shares: 618400000.00
AGNC income_statement (annual, 2023-12-31) — Basic EPS: 0.05
AGNC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 2334000000.00
AGNC balance_sheet (annual, 2023-12-31) — Capital Stock: 1641000000.00
AGNC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 518000000.00
AGNC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13389000000.00
AGNC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1005000000.00
AGNC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 14227000000.00
AGNC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -14672000000.00
AGNC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -118000000.00
AGNC cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -892000000.00
AGNC cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 904000000.00
AGNC cash_flow (annual, 2023-12-31) — Change In Working Capital: 12000000.00
AGNC cash_flow (annual, 2023-12-31) — Changes In Cash: -563000000.00
AGNC balance_sheet (annual, 2023-12-31) — Common Stock: 7000000.00
AGNC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6623000000.00
AGNC cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1085000000.00
AGNC cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
AGNC balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 362000000.00
AGNC income_statement (annual, 2023-12-31) — Diluted Average Shares: 619600000.00
AGNC income_statement (annual, 2023-12-31) — Diluted EPS: 0.05
AGNC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 32000000.00
AGNC balance_sheet (annual, 2023-12-31) — Dividends Payable: 115000000.00
AGNC cash_flow (annual, 2023-12-31) — End Cash Position: 1771000000.00
AGNC cash_flow (annual, 2023-12-31) — Financing Cash Flow: 14227000000.00
AGNC cash_flow (annual, 2023-12-31) — Free Cash Flow: -118000000.00
AGNC cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 1567000000.00
AGNC income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 497000000.00
AGNC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -517000000.00
AGNC income_statement (annual, 2023-12-31) — General And Administrative Expense: 62000000.00
AGNC balance_sheet (annual, 2023-12-31) — Goodwill: 526000000.00
AGNC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNC income_statement (annual, 2023-12-31) — Interest Expense: 2287000000.00
AGNC income_statement (annual, 2023-12-31) — Interest Income: 2041000000.00
AGNC cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2246000000.00
AGNC balance_sheet (annual, 2023-12-31) — Invested Capital: 6703000000.00
AGNC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -14672000000.00
AGNC balance_sheet (annual, 2023-12-31) — Investments And Advances: 4242000000.00
AGNC cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1085000000.00
AGNC balance_sheet (annual, 2023-12-31) — Long Term Debt: 80000000.00
AGNC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 80000000.00
AGNC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -17000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 1085000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income: 155000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 32000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 155000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 155000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 155000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 155000000.00
AGNC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 155000000.00
AGNC income_statement (annual, 2023-12-31) — Net Interest Income: -246000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -10162000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -17000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -17000000.00
AGNC cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
AGNC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 7731000000.00
AGNC income_statement (annual, 2023-12-31) — Normalized Income: 155000000.00
AGNC cash_flow (annual, 2023-12-31) — Operating Cash Flow: -118000000.00
AGNC cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1181000000.00
AGNC income_statement (annual, 2023-12-31) — Operating Revenue: 251000000.00
AGNC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 694300000.00
AGNC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -517000000.00
AGNC income_statement (annual, 2023-12-31) — Other Non Interest Expense: 34000000.00
AGNC balance_sheet (annual, 2023-12-31) — Other Payable: 210000000.00
AGNC balance_sheet (annual, 2023-12-31) — Payables: 325000000.00
AGNC balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 325000000.00
AGNC balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 54500000.00
AGNC balance_sheet (annual, 2023-12-31) — Preferred Stock: 1634000000.00
AGNC income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 123000000.00
AGNC balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 1634000000.00
AGNC cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
AGNC income_statement (annual, 2023-12-31) — Pretax Income: 155000000.00
AGNC cash_flow (annual, 2023-12-31) — Purchase Of Investment: -63115000000.00
AGNC balance_sheet (annual, 2023-12-31) — Receivables: 0.00
AGNC cash_flow (annual, 2023-12-31) — Repayment Of Debt: -17000000.00
AGNC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
AGNC balance_sheet (annual, 2023-12-31) — Retained Earnings: -8148000000.00
AGNC income_statement (annual, 2023-12-31) — Salaries And Wages: 62000000.00
AGNC cash_flow (annual, 2023-12-31) — Sale Of Investment: 52953000000.00
AGNC income_statement (annual, 2023-12-31) — Selling General And Administration: 62000000.00
AGNC balance_sheet (annual, 2023-12-31) — Share Issued: 694300000.00
AGNC cash_flow (annual, 2023-12-31) — Stock Based Compensation: 11000000.00
AGNC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 8257000000.00
AGNC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6097000000.00
AGNC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AGNC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
AGNC balance_sheet (annual, 2023-12-31) — Total Assets: 71596000000.00
AGNC balance_sheet (annual, 2023-12-31) — Total Capitalization: 8337000000.00
AGNC balance_sheet (annual, 2023-12-31) — Total Debt: 80000000.00
AGNC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 8257000000.00
AGNC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 63339000000.00
AGNC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
AGNC cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -1678000000.00
AGNC balance_sheet (quarterly, 2024-09-30) — Other Receivables: 1706000000.00
AGNC income_statement (annual, 2024-12-31) — +Total Revenue: 973000000.00
AGNC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 17264000000.00
AGNC balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 5577000000.00
AGNC income_statement (annual, 2024-12-31) — Basic Average Shares: 783400000.00
AGNC income_statement (annual, 2024-12-31) — Basic EPS: 0.93
AGNC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1771000000.00
AGNC balance_sheet (annual, 2024-12-31) — Capital Stock: 1643000000.00
AGNC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 505000000.00
AGNC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18908000000.00
AGNC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1241000000.00
AGNC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 11083000000.00
AGNC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -11169000000.00
AGNC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 86000000.00
AGNC cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 738000000.00
AGNC cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -701000000.00
AGNC cash_flow (annual, 2024-12-31) — Change In Working Capital: 37000000.00
AGNC cash_flow (annual, 2024-12-31) — Changes In Cash: 0.00
AGNC balance_sheet (annual, 2024-12-31) — Common Stock: 9000000.00
AGNC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 8128000000.00
AGNC cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1967000000.00
AGNC cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
AGNC balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 94000000.00
AGNC income_statement (annual, 2024-12-31) — Diluted Average Shares: 786000000.00
AGNC income_statement (annual, 2024-12-31) — Diluted EPS: 0.93
AGNC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 731000000.00
AGNC balance_sheet (annual, 2024-12-31) — Dividends Payable: 143000000.00
AGNC cash_flow (annual, 2024-12-31) — End Cash Position: 1771000000.00
AGNC cash_flow (annual, 2024-12-31) — Financing Cash Flow: 11083000000.00
AGNC cash_flow (annual, 2024-12-31) — Free Cash Flow: 86000000.00
AGNC cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 188000000.00
AGNC income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 955000000.00
AGNC balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -591000000.00
AGNC income_statement (annual, 2024-12-31) — General And Administrative Expense: 74000000.00
AGNC balance_sheet (annual, 2024-12-31) — Goodwill: 526000000.00
AGNC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNC income_statement (annual, 2024-12-31) — Interest Expense: 2931000000.00
AGNC income_statement (annual, 2024-12-31) — Interest Income: 2949000000.00
AGNC cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2899000000.00
AGNC balance_sheet (annual, 2024-12-31) — Invested Capital: 8192000000.00
AGNC balance_sheet (quarterly, 2024-12-31) — Invested Capital: 8192000000.00
AGNC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -11169000000.00
AGNC balance_sheet (annual, 2024-12-31) — Investments And Advances: 5577000000.00
AGNC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1967000000.00
AGNC balance_sheet (annual, 2024-12-31) — Long Term Debt: 64000000.00
AGNC balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 64000000.00
AGNC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 64000000.00
AGNC balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 64000000.00
AGNC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -15000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1967000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income: 863000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 731000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 863000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 863000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 863000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 863000000.00
AGNC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 863000000.00
AGNC income_statement (annual, 2024-12-31) — Net Interest Income: 18000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -6376000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -15000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -15000000.00
AGNC cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
AGNC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 9236000000.00
AGNC income_statement (annual, 2024-12-31) — Normalized Income: 863000000.00
AGNC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 86000000.00
AGNC cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1840000000.00
AGNC income_statement (annual, 2024-12-31) — Operating Revenue: 973000000.00
AGNC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 897400000.00
AGNC balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -591000000.00
AGNC income_statement (annual, 2024-12-31) — Other Non Interest Expense: 36000000.00
AGNC balance_sheet (annual, 2024-12-31) — Other Payable: 74000000.00
AGNC balance_sheet (annual, 2024-12-31) — Payables: 217000000.00
AGNC balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 217000000.00
AGNC balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 44500000.00
AGNC balance_sheet (annual, 2024-12-31) — Preferred Stock: 1634000000.00
AGNC income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 132000000.00
AGNC balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 1634000000.00
AGNC cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
AGNC income_statement (annual, 2024-12-31) — Pretax Income: 863000000.00
AGNC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -60844000000.00
AGNC balance_sheet (annual, 2024-12-31) — Receivables: 0.00
AGNC cash_flow (annual, 2024-12-31) — Repayment Of Debt: -15000000.00
AGNC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
AGNC balance_sheet (annual, 2024-12-31) — Retained Earnings: -8554000000.00
AGNC income_statement (annual, 2024-12-31) — Salaries And Wages: 74000000.00
AGNC cash_flow (annual, 2024-12-31) — Sale Of Investment: 54468000000.00
AGNC income_statement (annual, 2024-12-31) — Selling General And Administration: 74000000.00
AGNC balance_sheet (annual, 2024-12-31) — Share Issued: 897400000.00
AGNC cash_flow (annual, 2024-12-31) — Stock Based Compensation: 18000000.00
AGNC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 9762000000.00
AGNC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 7602000000.00
AGNC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AGNC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
AGNC balance_sheet (annual, 2024-12-31) — Total Assets: 88015000000.00
AGNC balance_sheet (annual, 2024-12-31) — Total Capitalization: 9826000000.00
AGNC balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 9826000000.00
AGNC balance_sheet (annual, 2024-12-31) — Total Debt: 64000000.00
AGNC balance_sheet (quarterly, 2024-12-31) — Total Debt: 64000000.00
AGNC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 9762000000.00
AGNC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 78253000000.00
AGNC cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 885000000.00
AGNC income_statement (quarterly, 2025-03-31) — +Total Revenue: 78000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 17769000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 7262000000.00
AGNC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 918300000.00
AGNC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.02
AGNC cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1771000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1643000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 455000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 19322000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -363000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 5482000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5727000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 192000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -17000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 43000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 26000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Changes In Cash: -53000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Common Stock: 9000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8408000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 509000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 70000000.00
AGNC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 921900000.00
AGNC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.02
AGNC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 15000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 148000000.00
AGNC cash_flow (quarterly, 2025-03-31) — End Cash Position: 1718000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 5482000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 192000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 245000000.00
AGNC income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -81000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -498000000.00
AGNC income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 19000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Goodwill: 526000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNC income_statement (quarterly, 2025-03-31) — Interest Expense: 687000000.00
AGNC income_statement (quarterly, 2025-03-31) — Interest Income: 846000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8470000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5727000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 7262000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 509000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 62000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 62000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -4000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 509000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income: 50000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 15000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 50000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 50000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 50000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 50000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 50000000.00
AGNC income_statement (quarterly, 2025-03-31) — Net Interest Income: 159000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -5466000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -4000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 9516000000.00
AGNC income_statement (quarterly, 2025-03-31) — Normalized Income: 50000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 192000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1264000000.00
AGNC income_statement (quarterly, 2025-03-31) — Operating Revenue: 78000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 949000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -498000000.00
AGNC income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 9000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Other Payable: 1843000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Payables: 1991000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1991000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 67500000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 1634000000.00
AGNC income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 35000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 1634000000.00
AGNC income_statement (quarterly, 2025-03-31) — Pretax Income: 50000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -17079000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Receivables: 1000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -8872000000.00
AGNC income_statement (quarterly, 2025-03-31) — Salaries And Wages: 19000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 11613000000.00
AGNC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 19000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Share Issued: 949000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -4000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10042000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7882000000.00
AGNC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AGNC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
AGNC balance_sheet (quarterly, 2025-03-31) — Total Assets: 95889000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10104000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Total Debt: 62000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10042000000.00
AGNC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 85847000000.00
AGNC cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -1183000000.00
AGNC income_statement (quarterly, 2025-06-30) — +Total Revenue: -112000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 18575000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 6002000000.00
AGNC income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1017300000.00
AGNC income_statement (quarterly, 2025-06-30) — Basic EPS: -0.17
AGNC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1718000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1644000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 656000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 23234000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -394000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3418000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3444000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 180000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -17000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 25000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 8000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Changes In Cash: 154000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Common Stock: 10000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8713000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 799000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 106000000.00
AGNC income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1017300000.00
AGNC income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.17
AGNC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -178000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 164000000.00
AGNC cash_flow (quarterly, 2025-06-30) — End Cash Position: 1872000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 3418000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 180000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 177000000.00
AGNC income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -274000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -450000000.00
AGNC income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Goodwill: 526000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 526000000.00
AGNC income_statement (quarterly, 2025-06-30) — Interest Expense: 668000000.00
AGNC income_statement (quarterly, 2025-06-30) — Interest Income: 830000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8773000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3444000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 6002000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 799000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 60000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 60000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 799000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income: -140000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -178000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -140000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -140000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -140000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -140000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -140000000.00
AGNC income_statement (quarterly, 2025-06-30) — Net Interest Income: 162000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 87000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 9821000000.00
AGNC income_statement (quarterly, 2025-06-30) — Normalized Income: -140000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 180000000.00
AGNC cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 544000000.00
AGNC income_statement (quarterly, 2025-06-30) — Operating Revenue: -112000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1041700000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -450000000.00
AGNC income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 10000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Other Payable: 392000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Payables: 556000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 556000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 67500000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 1634000000.00
AGNC income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 38000000.00
AGNC balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 1634000000.00